Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.64 |
| ▸ | SQLE | Q14534 | 7/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | FNTA | P49354 | 2/20 | 0.53 |
| ▸ | FNTB | P49356 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12555811 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL12412583 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL331851 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL3791172 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL3503739 | 0.98 | KMT2A (0.68) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL1472304 | 0.98 | KMT2A (0.68) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL332318 | 0.98 | KMT2A (0.68) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL8064939 | 0.86 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Squalene SCHEMBL28619973 | 0.86 | KMT2A (0.81) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Squalene SCHEMBL28619974 | 0.86 | KMT2A (0.81) | KMT2AMAPTMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217145-B2 | Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine | THE SCRIPS RESEARCH INSTITUTE (US) | 2012-07-10 | — | — | US | claimed |
| US-20090209000-A1 | Genetically Programmed Expression of Proteins | THE SCRIPPS RESEARCH INSTITUTE | 2009-08-20 | — | — | US | claimed |
| CN-101405401-A | Genetic programming expression of protein containing unnatural amino acid phenylselenocysteine | SCRIPPS RESEARCH INST (US) | 2009-04-08 | — | — | CN | claimed |
| EP-1994165-A2 | GENETICALLY PROGRAMMED EXPRESSION OF PROTEINS CONTAINING THE UNNATURAL AMINO ACID PHENYLSELENOCYSTEINE | The Scripps Research Institute (US) | 2008-11-26 | — | — | EP | claimed |
| US-20070238152-A1 | Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-10-11 | — | — | US | claimed |
| WO-2007109035-A2 | GENETICALLY PROGRAMMED EXPRESSION OF PROTEINS CONTAINING THE UNNATURAL AMINO ACID PHENYLSELENOCYSTEINE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-09-27 | — | — | WO | claimed |
| EP-0482342-A2 | Hypocholesterolemic unsymmetrical dithiol ketals | Bristol-Myers Squibb Company (US) | 1992-04-29 | — | — | EP | claimed |
| WO-2025030241-A1 | COATING MATERIALS BASED ON FUNCTIONALIZED ORGANIC MOLECULES AND USES THEREOF IN ELECTROCHEMICAL APPLICATIONS | HYDRO-QUéBEC (CA) | 2025-02-13 | — | — | WO | disclosed |
| US-20240017996-A1 | FLUORINATION PROCESSES | UNIVERSITY COLLEGE LONDON (GB) | 2024-01-18 | — | — | US | disclosed |
| US-20230339829-A1 | FLUORINATION PROCESSES | UNIVERSITY COLLEGE LONDON (GB) | 2023-10-26 | — | — | US | disclosed |
| WO-2023118867-A1 | CAF2-BASED FLUORINATION REAGENTS, METHODS OF PREPARATION AND USES THEREOF | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-06-29 | — | — | WO | disclosed |
| US-20160326212-A1 | Chemical Modification of Proteins | R.P. SCHERER TECHNOLOGIES, LLC | 2016-11-10 | — | — | US | disclosed |
| US-9346851-B2 | Chemical modification of proteins | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2016-05-24 | — | — | US | disclosed |
| WO-2008066816-A2 | DERIVATIZATION OR LIGATON OF PEPTIDES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2008-06-05 | — | — | WO | disclosed |
| US-20070238152-A1 | Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-10-11 | — | — | US | disclosed |
| WO-2007109035-A2 | GENETICALLY PROGRAMMED EXPRESSION OF PROTEINS CONTAINING THE UNNATURAL AMINO ACID PHENYLSELENOCYSTEINE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-09-27 | — | — | WO | disclosed |
| EP-0640590-A1 | Process for the synthesis of 4-mercaptophenols and naphthalenols | Bristol-Myers Company (US) | 1995-03-01 | — | — | EP | disclosed |
| US-5321046-A | Hypocholesterolemic unsymmetrical dithiol ketals | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-06-14 | — | — | US | disclosed |
| EP-0482342-A2 | Hypocholesterolemic unsymmetrical dithiol ketals | Bristol-Myers Squibb Company (US) | 1992-04-29 | — | — | EP | disclosed |
| US-4067910-A | HEATING ALLYL XANTHOGENATE | GIVAUDAN CORPORATION (US) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238152-A1 | Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine | NPEPPS, AARS1, NSUN3 | KMT2A 1397/4885MAPT 3007/4885MEN1 4532/4885 |
| US-20230339829-A1 | FLUORINATION PROCESSES | PPIP5K2, PFAS, ARFGEF1 | KMT2A 3626/4885MAPT 3067/4885MEN1 397/4885 |
| US-20160326212-A1 | Chemical Modification of Proteins | SCLY, PTMS, QPCT | KMT2A 2362/4885MAPT 3827/4885MEN1 3233/4885 |
| US-20090209000-A1 | Genetically Programmed Expression of Proteins | AARS1, COASY, NPEPPS | KMT2A 1806/4885MAPT 2947/4885MEN1 4588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.